Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Finds Physician Support For Wingspan Brain Stent Coverage

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific assures CMS that there is minimal risk in granting national coverage for its Wingspan brain vessel stent due to safeguards associated with the product's humanitarian device exemption
Advertisement

Related Content

Wingspan Coverage Policy Has Broad Implications For Humanitarian Devices
Wingspan Coverage Policy Has Broad Implications For Humanitarian Devices
Double Duty: Creating Trials To Satisfy Both FDA And CMS
Double Duty: Creating Trials To Satisfy Both FDA And CMS
CMS Opens NCD For Boston Scientific’s Wingspan Intracranial Stent
CMS Opens NCD For Boston Scientific’s Wingspan Intracranial Stent
Advertisement
UsernamePublicRestriction

Register

MT023328

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel